Gil-Bea FJ, Garcia-Alloza M, Dominguez J, Marcos B, Ramirez MJ (2005) Evaluation of cholinergic markers in Alzheimer’s disease and in a model of cholinergic deficit. Neurosci Lett 375(1):37-41. doi: 10.1016/j.neulet.2004.10.062
Summary: Several markers of cholinergic function may be able to predict cognitive deficits due to disorders such as Alzheimer’s disease. The authors compared baseline measurements of acetylcholine, cholinacetyltransferase, and acetylcholinesterase (AChE) of rats against animals treated with 0.067 µg injections of 192-Saporin (Cat. #IT-01) into both hemispheres of the nucleus basalis magnocellularis. The results indicate that measurement of AChE activity is an inexpensive and reliable method to evaluate cholinergic function in rats as well as in humans.
Related Products: 192-IgG-SAP (Cat. #IT-01)